Overview

HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Determine if different levels of acid-suppression with esomeprazole for 6 months on chosen histological markers of esophageal epithelial acid-related disease in patients with upper GI symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Esomeprazole